| http://purl.uniprot.org/citations/1555650 | http://www.w3.org/2004/02/skos/core#exactMatch | http://purl.uniprot.org/pubmed/1555650 |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/author | "Boisclair M."xsd:string |
| http://purl.uniprot.org/uniprot/#_P01008-citation-1555650 | http://www.w3.org/1999/02/22-rdf-syntax-ns#object | http://purl.uniprot.org/citations/1555650 |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/author | "Olds R.J."xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/volume | "300"xsd:string |
| http://purl.uniprot.org/uniprot/P01008 | http://purl.uniprot.org/core/citation | http://purl.uniprot.org/citations/1555650 |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/date | "1992"xsd:gYear |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/name | "FEBS Lett."xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://www.w3.org/1999/02/22-rdf-syntax-ns#type | http://purl.uniprot.org/core/Journal_Citation |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/author | "Lane D.A."xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://purl.org/dc/terms/identifier | "doi:10.1016/0014-5793(92)80854-a"xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/author | "Sas G."xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/pages | "241-246"xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://xmlns.com/foaf/0.1/primaryTopicOf | https://pubmed.ncbi.nlm.nih.gov/1555650 |
| http://purl.uniprot.org/uniprot/P01008#attribution-E688C87539EA651EEABEDCAA288B6F42 | http://purl.uniprot.org/core/source | http://purl.uniprot.org/citations/1555650 |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/author | "Bock S.C."xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/title | "Antithrombin Budapest 3. An antithrombin variant with reduced heparin affinity resulting from the substitution L99F."xsd:string |
| http://purl.uniprot.org/citations/1555650 | http://purl.uniprot.org/core/author | "Thein S.L."xsd:string |